Virtu Financial LLC Seelos Therapeutics, Inc. Transaction History

Virtu Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	BUY	$0.66 - $259.46 $22,792 - $8.96 Million	34,534 New	34,534 $23,000
Q1 2022 May 17, 2022	SELL	$0.84 - $1.71 $28,468 - $57,953	-33,891 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$1.59 - $2.38 $195,221 - $292,218	-122,781 Reduced 78.37%	33,891 $55,000
Q3 2021 Nov 12, 2021	BUY	$1.69 - $2.89 $119,729 - $204,744	70,846 Added 82.55%	156,672 $378,000
Q2 2021 Sep 17, 2021	BUY	$2.64 - $6.32 $226,580 - $542,420	85,826 New	85,826 $227,000
Q1 2021 May 19, 2021	SELL	$1.35 - $4.99 $114,615 - $423,651	-84,900 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$0.74 - $2.01 $62,826 - $170,648	84,900 New	84,900 $134,000
Q3 2020 Dec 11, 2020	SELL	$0.6 - $1.25 $57,815 - $120,448	-96,359 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$0.42 - $1.51 $40,470 - $145,502	96,359 New	96,359 $97,000
Q4 2019 Feb 04, 2020	SELL	$0.72 - $1.52 $53,338 - $112,603	-74,081 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$0.92 - $2.15 $68,154 - $159,274	74,081 New	74,081 $68,000

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $32M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.